#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicular lymphoma stage I Bladder cancer Angiosarcoma metastatic Gastrooesophageal cancer Liposarcoma Acute myeloid leukaemia (in remission) Homocystinuria Pericarditis Familial hypertriglyceridaemia Phenylketonuria Chronic myeloid leukaemia (in remission) Metabolic disorder Cardiac arrest Dermatitis Vascular malformation More trials…

    Learn about Rare Diseases

    Ornithine transcarbamoylase deficiency Cytokine release syndrome Shprintzen-Goldberg syndrome – Trials in Disease Medulloblastoma Testicular leiomyosarcoma – Treatment Glomerulonephritis membranoproliferative – Diagnostics Lymphatic malformation – Basic Information Focal segmental glomerulosclerosis – Basic Information Amyotrophic lateral sclerosis – Life with Disease Sarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Alxn1850 Emavusertib Salbutamol Sulfate Ph. Eur. Imidapril Hydrochloride Fipaxalparant Psma-11 Specific Nucleic Acid Sna-Her2 Mometasone Furoate SGN-ALPV Pemetrexed Diacid Monohydrate Clopidogrel Almagate Cilazapril HUMAN COAGULATION FACTOR XIII Gallium (68Ga) Elebsiran Imatinib Metoprolol Succinate Daridorexant Emicizumab More therapies…

    Learn about Your Condition

    Eructation Follicular thyroid cancer Pharyngeal cancer stage I Acute on chronic liver failure Metabolic disorder Insomnia Rheumatic disorder Gouty arthritis Dyskinesia Peripheral spondyloarthritis Sinusitis bacterial Endometrial cancer metastatic Breast cancer stage I Deafness Iron deficiency anaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal and Neural Physiological Phenomena

  • Study on the Effects of Triumeq (Abacavir Sulfate, Lamivudine, Dolutegravir Sodium) in Patients with Amyotrophic Lateral Sclerosis (ALS)

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Abacavir Sulfate
    • Dolutegravir Sodium
    • Lamivudine
    Ireland The Netherlands Slovenia Spain Sweden

  • Study on Botulinum Toxin Type A and Capsaicin for Treating Postmastectomy Pain in Women After Breast Cancer Surgery

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Capsaicin
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    Spain

  • Study on Iloprost for Improving Bone Healing in Patients with Upper Arm Fracture

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Upper limb fracture
    Investigated Drugs:
    • Iloprost Trometamol
    Germany

  • Study of Lithium Treatment for Patients with Amyotrophic Lateral Sclerosis (ALS) to Evaluate Survival Rate

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Belgium The Netherlands Spain Sweden

  • Study on the Effectiveness and Safety of LY06006 and Denosumab for Postmenopausal Women with Osteoporosis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Denosumab
    Bulgaria Czechia Poland

  • Study on Long-Term Safety and Effects of Vosoritide in Children with Achondroplasia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteochondrodysplasia
    Investigated Drugs:
    • Vosoritide
    France
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!